Singapore markets closed
Straits Times Index
3,130.24 +15.16 (+0.49%) Nikkei
25,937.21 -484.84 (-1.83%) Hang Seng
17,222.83 +56.96 (+0.33%) FTSE 100
6,893.81 +12.22 (+0.18%) BTC-USD
19,240.24 -254.37 (-1.30%) CMC Crypto 200
443.49 +0.06 (+0.01%)
Prothena Corporation plc (PRTA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 59.47 |
| Open | 59.00 |
| Bid | 60.52 x 1400 |
| Ask | 61.00 x 800 |
| Day's range | 58.83 - 64.00 |
| 52-week range | 21.06 - 74.32 |
| Volume | |
| Avg. volume | 610,019 |
| Market cap | 2.845B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 41.24 |
| EPS (TTM) | N/A |
| Earnings date | 01 Nov 2022 - 04 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 73.78 |
- Zacks
LLY & PRTA in Spotlight on BIIB-Eisai's AD Drug Data
The success of Biogen (BIIB)-Eisai's AD candidate in a big phase III study makes investors optimistic about the prospects of other AD candidates as well.
- Motley Fool
Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today
Shares of Biogen (NASDAQ: BIIB) were skyrocketing 36% as of 11:10 a.m. ET on Wednesday. The huge gain came after the company and its partner Eisai (OTC: ESALY) announced positive results on Tuesday from their late-stage Clarity AD study evaluating lecanemab in treating Alzheimer's disease. The news also propelled two stocks of other drugmakers developing Alzheimer's disease drugs significantly higher.
- Zacks
Prothena (PRTA) Down 16.9% Since Last Earnings Report: Can It Rebound?
Prothena (PRTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2022 Yahoo. All rights reserved.
